THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14

Looking Forward: Novartis Commitment to Rheumatology

November 12 from 6:30 pm 8:30 pm EST

Philadelphia Marriott Downtown hotel in Grand Ballroom G

At Novartis, we are reimagining medicine. We challenge medical paradigms and use innovative science and technology to address long-standing challenges in rheumatology. Our quest to improve patients’ lives has made Novartis a global leader in treating many rheumatological diseases, and we are committed to expanding our focus to target underserved diseases.

Join presenters Dr Anthony Yadao and Dr Adam Winseck, as they discuss our legacy in rheumatology and our continued commitment to developing transformative treatments for rheumatic diseases. Dr Yadao and Dr Winseck will examine 4 diseases with gaps in patient care: Lupus nephritis, Sjögren’s, giant cell arteritis, and polymyalgia rheumatica. They will discuss the patient burden, unmet needs, and pathophysiology of these 4 diseases to highlight opportunities for improved patient care.

Learning objectives:

  • Review Novartis commitment to medical innovation in rheumatology
  • Examine Novartis past journey in rheumatology
  • Discuss the patient burden and unmet needs of lupus nephritis, Sjögren’s, giant cell arteritis, and polymyalgia rheumatica
  • Reflect on the pathophysiology of these 4 diseases

This program is developed and offered by Novartis US Medical Affairs.
This is not a CME program.

Speakers:

Adam Winseck PhD, MBA
Novartis Pharmaceuticals Corporation
Novartis US Clinical Development and Medical Affairs
Head of Rheumatology Medical Affairs
East Hanover, New Jersey

Anthony Yadao MD
Novartis Pharmaceuticals Corporation
Novartis US Clinical Development and Medical Affairs
VP, Head of Immunology Medical Affairs
East Hanover, New Jersey

Novartis Pharmaceuticals Corporation (NPC) may not be able to offer you food or beverages if you are licensed by a state with a meal limit or prohibition, if you are a government employee or member of a formulary committee, or if your institution or affiliation prohibits your acceptance of a meal from a pharmaceutical industry representative. NPC relies on you to ensure mutual compliance with all applicable laws and policies.

Novartis acts in accordance with the PhRMA Code on Interactions with Health Care Professionals. The PhRMA Code states that inclusion of a health care professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to provide a high-quality learning environment for all participating health care professionals. Thank you.

This is not an official program of the American College of Rheumatology.